Pact
Entrepreneur First '20London, GB · Founded 2020 · 4 known investors
Find your way into Pact
642 people in our graph share verified history with the Pact team — schools, employers, funds. One of them is your warm intro.
PACT develops earth-positive biomaterials for the fashion industry, scaling them up for supply to partner brands. The company runs a research and development laboratory and pilot facilities where scientists, engineers and designers create sustainable materials.
Also known as PACT · PACT Biomaterials
Founders & leadership
Pact was founded in 2020 by Yudi Ding and Niels Ramay.


Investors · 4
Company profile
researched Aug 2026PACT is a biomaterials developer that designs materials from natural inputs including collagen, herbal extracts, oils and minerals. Its flagship product, Oval, is a supple, skin-like material made from collagen rather than plastic. According to the company, collagen is a structural protein widely used in high-end cosmetics, skincare and pharmaceuticals, and PACT's patented process converts cosmetic-grade collagen into "collagen skins" that are enriched with all-natural ingredients and then treated with established finishing techniques.
The company positions Oval as a performance material tested against the craftsmanship requirements of luxury goods, claiming that its collagen base delivers flexibility, handfeel and broad customisation options — including precise colour matching and intricate embellishments — relative to materials derived from other biomass sources. PACT describes Oval as the first material to harness recovered collagen for design use, and emphasises traceability in how the material is made.
Beyond Oval, PACT states that its headquarters functions as a laboratory for material experimentation where scientists are developing a suite of biomaterials for consumer industries. The company also operates a pilot plant where it tests adaptable biomaterials at industrial scale for sectors beyond fashion, citing furniture and automotive as target applications. Its team is described as comprising scientists, engineers, creatives and investors, supported by an advisory panel.
Business model
PACT supplies its biomaterials to brand customers, which it refers to as "Maison partners," through bespoke, collaborative engagements. The website invites brands to work with PACT on applying its technology, and states the material is designed to integrate into existing supply chains, though no pricing, contract structure or revenue figures are disclosed in the available sources.
Traction
The available sources do not disclose named customers, revenue, volumes or funding for PACT. The company states that Oval has been rigorously tested against luxury-goods manufacturing techniques and that it is testing biomaterials at industrial scale at its laboratory and pilot plant.
Latest developments
PACT states that its scientists are developing a broader suite of biomaterials beyond Oval for consumer industries, and that it is testing adaptable biomaterials at industrial scale at its laboratory and pilot plant with the aim of serving sectors such as furniture and automotive. It is also advertising career opportunities.
▸Full profile — market position, technology, go-to-market, geography, risks & controversies
Market position
PACT positions itself as a supplier of lower-impact alternatives to plastic-based materials for the luxury and creative industries, differentiating from other biomass-derived materials on the basis of its collagen feedstock. It frames its offering against tightening ESG legislation, mandatory climate disclosures and regulatory scrutiny of greenwashing. No market share, revenue or comparative competitive data is available in the sources.
PACT claims Oval is the first material to use recovered collagen for design applications, and that the collagen base provides greater flexibility, handfeel and customisation than materials made from other biomass sources. Additional stated points of difference include a patented conversion process, a production process without harsh chemicals, traceability, and compatibility with existing supply chains.
Technology
PACT's core technology is a patented process that transforms cosmetic-grade collagen into collagen skins, which are then enriched with all-natural ingredients and finished using established techniques. The company states its production uses no harsh chemicals, thereby minimising water pollution and reducing worker exposure to hazardous substances, and that its collagen input is a byproduct otherwise used in cosmetics, skincare and pharmaceuticals. PACT operates a laboratory and a pilot plant for developing and testing further biomaterials at industrial scale.
Go-to-market
PACT markets directly to brands and designers through its website, positioning itself as a design-forward partner offering bespoke technology and creative collaboration. It maintains contact and "work with us" channels for prospective brand partners, a newsletter for product innovation and design news, and a careers page for hiring.
Luxury and design-led brands (described by PACT as "Maison partners") and designers working in fashion and luxury goods. The company also states it is developing materials for industries beyond fashion, naming furniture and automotive as examples.
Geography
The public sources do not specify locations; PACT refers only to its headquarters, which houses its laboratory, and to a pilot plant.
Risks & controversies
No controversies are documented in the available sources. The company's own materials note that evolving global ESG legislation and regulatory action on greenwashing shape the environment in which it operates. Environmental and performance claims in the sources are self-reported by PACT and are not independently verified in the material reviewed. Note also that several similarly named but unrelated companies exist in fintech and blockchain sectors, which complicates public-record research on this company.
Compiled by commissioned research from 8 cited public sources — announcements, filings, and press listed under research sources below.
Companies House · registry record
View on Companies House ↗- Registered name
- PACT LIMITED
- Company number
- 00787969
- Status
- Active
- Company type
- Private limited company
- Incorporated
- 14 Jan 1964
- Registered office
- White House, Wollaton Street, Nottingham, Notts, NG1 5GF
- Nature of business (SIC)
- 68201 — Renting and operating of Housing Association real estate
- Accounts
- last made up to 31 Dec 2025 · next due 30 Sept 2027
- Confirmation statement
- last made up to 7 May 2026 · next due 21 May 2027
Current officers · 3
- Margarita Timmans — secretary
- Elspeth Barbara Timmans — director, appointed 22 Feb 2024
- Mark Richard Timmans — director, appointed 22 Feb 2024
Source: Companies House public register · retrieved 23 Aug 2026. Contains public sector information licensed under the Open Government Licence v3.0.
In the news
▸Research sources · 8
primary sources listed
- Pactpact.earth · web
8 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Pact do?
- PACT develops collagen-based biomaterials, led by its Oval material, as alternatives to plastic-based materials for luxury brands.
- Who founded Pact?
- Pact was founded by Yudi Ding, Niels Ramay in 2020.
- Who are Pact's investors?
- Pact's investors include Carbon, Entrepreneur First, Hoxton Ventures, Polytechnique Ventures.
- Where is Pact headquartered?
- Pact is headquartered in London, GB.

